Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase EARLY_PHASE1 1

Status

Recruiting 6Unknown 5Not yet recruiting 5Active not recruiting 3Terminated 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Other neoplasm 1

Conditions

Breast Neoplasms 309Carcinoma, Non-Small-Cell Lung 281Prostatic Neoplasms 160Colorectal Neoplasms 155Carcinoma, Hepatocellular 144Neoplasms 134Leukemia, Myeloid, Acute 132Lung Neoplasms 115Squamous Cell Carcinoma of Head and Neck 108Multiple Myeloma 103Triple Negative Breast Neoplasms 102Recurrence 99Pancreatic Neoplasms 93Stomach Neoplasms 92Ovarian Neoplasms 87Neoplasm Metastasis 87Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Esophageal Neoplasms 67Uterine Cervical Neoplasms 66Melanoma 65Brain Neoplasms 65Rectal Neoplasms 62Head and Neck Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 57Myelodysplastic Syndromes 55Lymphoma 55Esophageal Squamous Cell Carcinoma 54

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2taxane 1sintilimab 1XELOX 1Tegafur 1Taxes 1Tadalafil 1Platinum 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Gastrectomy 1Cytoreduction Surgical Procedures 1Cisplatin 1Capecitabine 1Albumin-Bound Paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Gastric Adenocarcinoma × Clear all
NCT07178808 2026-05-01

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Banner Health

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

NCT07263386 2025-12-04

ARTEMIS-GC3

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
460 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT05709574 2025-10-16

Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

University of Arizona

Phase 2 Recruiting
10 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT06496789 2024-07-11

Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT06196697 2024-06-27

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Harbin Medical University

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡